Top

Reproductive Biology and Endocrinology

Published in:

Open Access 01-12-2021 | Research

Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis

Authors: Jun-Hua Huang, Hua Duan, Sha Wang, Yi-Yi Wang, Cheng-Xiao LV

Published in: Reproductive Biology and Endocrinology | Issue 1/2021

Abstract

Background

Let-7a is a small non-coding RNA that has been found to take part in cell proliferation and apoptosis. The hippo-YAP1 axis, known as a tumour suppressor pathway, also plays an important role in cell proliferation and apoptosis. YAP1, TAZ, and phospho-YAP1 play key roles in actions of the hippo-YAP1 axis. Adenomyosis (ADS) is a proliferative disease leading to a large uterus in patients with prolonged illness. Abnormal proliferation of smooth muscle cells (SMCs) in the uterine endometrial-myometrial junctional zone (JZ) is an important reason for developing ADS. This study aimed to explore the expression levels of let-7a and components of the hippo-YAP1 axis in SMCs in the uterine endometrial-myometrial JZ in ADS and to explore the roles of let-7a and the hippo-YAP1 axis of JZ SMC proliferation and apoptosis in ADS.

Methods

We collected JZ tissues for the primary culture of SMCs from 25 women diagnosed with ADS and 27 women without ADS. We used quantitative real-time polymerase chain reaction and western blotting to measure the mRNA and protein expression levels of let-7a, YAP1, TAZ, and phospho-YAP1 in ADS JZ SMCs. A CCK-8 assay and flow cytometry analysis of apoptosis were utilized to test the proliferation and apoptosis of JZ SMCs. The let-7a overexpression lentiviral vector GV280 was used to increase the expression level of let-7a. We added verteporfin to block the phosphorylation of components of the hippo-YAP1 axis.

Results

We found that the let-7a level was decreased, while the YAP1 and TAZ levels were increased in ADS JZ SMCs. Upregulated let-7a affected the expression levels of components of the hippo-YAP1 axis, accelerated apoptosis, and inhibited proliferation in JZ SMCs. Furthermore, accumulated YAP1 led to increasing proliferation of JZ SMCs after verteporfin treatment to block the phosphorylation of components of the hippo-YAP1 axis. If components of the hippo-YAP1 axis were unphosphorylated, upregulated let-7a could not inhibit the proliferation of ADS JZ SMCs. Upregulated let-7a could not activate the hippo-YAP1 axis in verteporfin treatment.

Conclusions

Our findings suggest that the let-7a and hippo-YAP1 axis may act as important regulators of JZ SMCs proliferation, and upregulated let-7a may be an effective method to treat ADS.

Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000;95(5):688–91. https://doi.org/10.1016/s0029-7844(99)00659-6.CrossRefPubMed

Novellas S, Chassang M, Delotte J, Toullalan O, Chevallier A, Bouaziz J, et al. MRI characteristics of the uterine junctional zone: from normal to the diagnosis of adenomyosis. AJR Am J Roentgenol. 2011;196(5):1206–13. https://doi.org/10.2214/AJR.10.4877.CrossRefPubMed

Mehasseb MK, Bell SC, Pringle JH, Habiba MA. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril. 2010;93(7):2130–6. https://doi.org/10.1016/j.fertnstert.2009.01.097.CrossRefPubMed

Fusi L, Cloke B, Brosens JJ. The uterine junctional zone. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):479–91. https://doi.org/10.1016/j.bpobgyn.2006.02.001.CrossRefPubMed

Brosens JJ, Barker FG, de Souza NM. Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus. Hum Reprod Update. 1998;4(5):496–502. https://doi.org/10.1093/humupd/4.5.496.CrossRefPubMed

Wang BG, Jiang LY, Xu Q. Let-7A comprehensive evaluation for polymorphisms in family in cancer risk and prognosis: a system review and meta-analysis. Biosci Rep. 2018;38(4):BSR20180273. https://doi.org/10.1042/BSR20180273.

Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer. 2010;17(1):F19–36. https://doi.org/10.1677/ERC-09-0184.CrossRefPubMed

Wang YY, Ren T, Cai YY, He XY. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm. 2013;28(2):131–7. https://doi.org/10.1089/cbr.2012.1307.CrossRefPubMed

Cai K, Wan Y, Sun G, Shi L, Bao X, Wang Z. Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells. Oncol Rep. 2012;28(6):2101–6. https://doi.org/10.3892/or.2012.2027.CrossRefPubMed

10.

Colamaio M, Calì G, Sarnataro D, Borbone E, Pallante P, Decaussin-Petrucci M, et al. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene. J Clin Endocrinol Metab. 2012;97(11):E2168–78. https://doi.org/10.1210/jc.2012-1929.CrossRefPubMed

11.

Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120–33. https://doi.org/10.1016/j.cell.2007.07.019.CrossRefPubMedPubMedCentral

12.

Huang J, Wu S, Barrera J, Matthews K, Pan D. The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122(3):421–34. https://doi.org/10.1016/j.cell.2005.06.007.CrossRefPubMed

13.

Ma S, Meng Z, Chen R, Guan KL. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2019;88:577–604. https://doi.org/10.1146/annurev-biochem-013118-111829. Epub 2019 Dec 19.

14.

Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8. https://doi.org/10.1038/nprot.2008.73.CrossRefPubMed

15.

Wu T, Chen X, Peng R, Liu H, Yin P, Peng H, et al. Let-7a suppresses cell proliferation via the TGF-β/SMAD signaling pathway in cervical cancer. Oncol Rep. 2016;36(6):3275–82. https://doi.org/10.3892/or.2016.5160.CrossRefPubMed

16.

Luo C, Zhang J, Zhang Y, Zhang X, Chen Y, Fan W. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma. Cell cycle (Georgetown, Tex.). 2020;19:1983–93.CrossRef

17.

Tian B, Huo N, Li M, Li Y, He Z. Let-7a and its target, insulin-like growth factor 1 receptor, are differentially expressed in recurrent prostate cancer. Int J Mol Med. 2015;36(5):1409–16. https://doi.org/10.3892/ijmm.2015.2357.CrossRefPubMed

18.

Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747–61. https://doi.org/10.1101/gad.1602907.CrossRefPubMedPubMedCentral

19.

Guo L, Teng L. YAP/TAZ for cancer therapy: opportunities and challenges (review). Int J Oncol. 2015;46(4):1444–52. https://doi.org/10.3892/ijo.2015.2877.CrossRefPubMed

20.

Nandy SB, Arumugam A, Subramani R, Pedroza D, Hernandez K, Saltzstein E, et al. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway. Oncotarget. 2015;6(19):17366–78. https://doi.org/10.18632/oncotarget.3953.CrossRefPubMedPubMedCentral

21.

Hua K, Jin J, Zhao J, Song J, Song H, Li D, et al. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. Int J Oncol. 2016;48(5):1997–2006. https://doi.org/10.3892/ijo.2016.3405.CrossRefPubMed

22.

Ruan T, He X, Yu J, Hang Z. MicroRNA-186 targets yes-associated protein 1 to inhibit hippo signaling and tumorigenesis in hepatocellular carcinoma. Oncol Lett. 2016;11(4):2941–5. https://doi.org/10.3892/ol.2016.4312.CrossRefPubMedPubMedCentral

23.

Deng J, Lei W, Xiang X, Zhang L, Lei J, Gong Y, et al. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the hippo signaling pathway. Oncotarget. 2016;7(9):10037–50. https://doi.org/10.18632/oncotarget.7048.CrossRefPubMedPubMedCentral

24.

Di Pietro C, Caruso S, Battaglia R, Iraci Sareri M, La Ferlita A, Strino F, et al. MiR-27a-3p and miR-124-3p, upregulated in endometrium and serum from women affected by Chronic Endometritis, are new potential molecular markers of endometrial receptivity. American journal of reproductive immunology (New York, N.Y. : 1989). 2018;80:e12858.CrossRef

25.

Sha L, Huang L, Luo X, Bao J, Gao L, Pan Q, et al. Long non-coding RNA LINC00261 inhibits cell growth and migration in endometriosis. J Obstet Gynaecol Res. 2017;43(10):1563–9. https://doi.org/10.1111/jog.13427.CrossRefPubMed

26.

Wu J, Jin L, Zhang Y, Duan A, Liu J, Jiang Z, et al. LncRNA HOTAIR promotes endometrial fibrosis by activating TGF-β1/Smad pathway. Acta Biochim Biophys Sin. 2020;52(12):1337–47. https://doi.org/10.1093/abbs/gmaa120.CrossRefPubMed

27.

Li T, Greenblatt EM, Shin ME, Brown TJ, Chan C. Cargo small non-coding RNAs of extracellular vesicles isolated from uterine fluid associate with endometrial receptivity and implantation success. Fertility Sterility. 2021;115(5):1327–1336. https://doi.org/10.1016/j.fertnstert.2020.10.046. Epub 2020 Dec 4.

28.

Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, et al. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet. 2016;294(5):897–904. https://doi.org/10.1007/s00404-016-4195-6.CrossRefPubMed

29.

Sturlese E, Salmeri FM, Retto G, Pizzo A, De Dominici R, Ardita FV, et al. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol. 2011;92(1-2):74–81. https://doi.org/10.1016/j.jri.2011.08.005.CrossRefPubMed

30.

Salmeri FM, Laganà AS, Sofo V, Triolo O, Sturlese E, Retto G, et al. Behavior of tumor necrosis factor-αand tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod Sci. 2014;22:165–72.CrossRefPubMed

31.

Inoue S, Hirota Y, Ueno T, Fukui Y, Yoshida E, Hayashi T, et al. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat Commun. 2019;10(1):5785. https://doi.org/10.1038/s41467-019-13708-y.CrossRefPubMedPubMedCentral

32.

Laganà AS, Scioscia M. Endometrial Cancer in women with Adenomyosis: an underestimated risk? Int J fertility sterility. 2020;14(3):260–1. https://doi.org/10.22074/ijfs.2020.44413.CrossRef

33.

Scioscia M, Noventa M, Laganà AS. Abnormal uterine bleeding and the risk of endometrial cancer: can subendometrial vascular ultrasound be of help to discriminate cancer from adenomyosis? Am J Obstet Gynecol. 2020;223(4):605–6. https://doi.org/10.1016/j.ajog.2020.05.049.CrossRefPubMed

Title: Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis
Authors: Jun-Hua Huang
Hua Duan
Sha Wang
Yi-Yi Wang
Cheng-Xiao LV
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: Reproductive Biology and Endocrinology / Issue 1/2021
Electronic ISSN: 1477-7827
DOI: https://doi.org/10.1186/s12958-021-00753-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Correction to: OTOGL, a gelforming mucin protein, is nonessential for male germ cell development and spermatogenesis in mice

Effect of resveratrol on mouse ovarian vitrification and transplantation

Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice

Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients

Immediate versus delayed frozen embryo transfer in women following a failed IVF-ET attempt: a multicenter randomized controlled trial

Individualized embryo selection strategy developed by stacking machine learning model for better in vitro fertilization outcomes: an application study